Americas · Financial press · El Financiero

Médicos ‘aplauden’ resultados de vacuna contra el melanoma de Moderna que ‘tiró’ acciones en Wall Street

Published by El Financiero · Mexico 2 h ago

La vacuna experimental contra el melanoma de Moderna y Merck redujo 42% el riesgo de recurrencia del cáncer y 38% la probabilidad de que se propague a otros órganos.

Read the full article on El Financiero Sign in to save

MarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.elfinanciero.com.mx)

Also worth reading

The Globe and Mail (Report on Business)

Loblaw says March data breach affected about 2 million customers

Valor Econômico

Médicos ‘aplauden’ resultados de vacuna contra el melanoma de Moderna que ‘tiró’ acciones en Wall Street

Share

Also worth reading

Loblaw says March data breach affected about 2 million customers

FT: Startup dos EUA capta US$ 200 milhões para criar cães ‘geneticamente aprimorados’ para fins militares